Paper36924769
Macrophages at the interface of the co-evolving cancer ecosystem.
Kloosterman DJ and 1 other. Cell, 2023. Cited by 344 papers, by iCite.
Cite this record
ConductScience Library. Macrophages at the interface of the co-evolving cancer ecosystem. Papers, record 36924769. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36924769
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Tumor Microenvironment | Major topic |
| Tumor-Associated Macrophages | Major topic |
| Humans |
Source PubMed
Cited by252
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 344 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42988898 | Multiscale multimodal integration of spatial omics through a deep generative model with CORAL. | Nat Genet | 2026 | https://conductscience.org/library/papers/42988898 | PubMed |
| 42972117 | Myeloid-derived TGFβ1 and oncostatin M establish two distinct stromal niches controlling late and hybrid EMT states. | Nat Cancer | 2026 | https://conductscience.org/library/papers/42972117 | PubMed |
| 42966886 | Integrated Multiomic Analysis Reveals an EBV-Associated MIF-SPP1+ Macrophage Axis Linking Tumor Stemness and Immune Dysfunction in Nasopharyngeal Carcinoma. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42966886 | PubMed |
| 42946787 | Targeting exosomal circSENP5 prevents immune escape of macrophages in pMMR-CRC via regulating mitochondrial metabolism. | Oncogene | 2026 | https://conductscience.org/library/papers/42946787 | PubMed |
| 42907426 | Histone deacetylase inhibition induces an antitumor IRF8-dependent trained immunity-like status in macrophages. | Nat Commun | 2026 | https://conductscience.org/library/papers/42907426 | PubMed |
| 42892644 | CXCL14+ fibroblasts promote development of IBD-associated fibrosis and cancer by interacting with SPP1+ macrophages via collagen IV secretion. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42892644 | PubMed |
| 42891212 | Beyond M1 M2: single-cell insights into how glioblastoma reshapes tumour-associated macrophages. | Front Immunol | 2026 | https://conductscience.org/library/papers/42891212 | PubMed |
| 42857493 | Natural metabolites targeting macrophage polarization for non-small cell lung cancer therapy: a review of mechanisms and applications based on chemical classification. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42857493 | PubMed |
| 42846924 | The multifaceted roles of tumor-infiltrating plasma cells in cancer immunology. | Fundam Res | 2026 | https://conductscience.org/library/papers/42846924 | PubMed |
| 42842669 | DNA nanodevice-engineered macrophages as living sensors for dual-mode in vivo monitoring of tumor-associated macrophage polarization. | Sci Adv | 2026 | https://conductscience.org/library/papers/42842669 | PubMed |
| 42840204 | GULP1 Fuels Resistance to PD-1 Blockade through Lipid-Mediated Metabolic Reprogramming of Tumor-Associated Macrophages in Gastric Cancer. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/42840204 | PubMed |
| 42839972 | An SPP1-centered immune-parenchymal communication axis links macrophage heterogeneity to ovarian cancer prognosis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42839972 | PubMed |
| 42830956 | Macrophage-Based Nanoplatforms for Tumor-Targeted Drug Delivery and Cancer Immunomodulation: Extracellular Vesicles, Membrane-Coated Nanoparticles, and Live Cells. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42830956 | PubMed |
| 42830947 | Immune-Cell Dynamics in the Tumor Microenvironment: Implications for Cancer Therapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42830947 | PubMed |
| 42819712 | An IGF2BP2-MYBL2-HMGB2 Signaling Axis Promotes Macrophage Immune Evasion in Hepatocellular Carcinoma. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/42819712 | PubMed |
| 42816487 | IFN-γ-driven iNOS induction in macrophages mediates CAR T cell resistance in B cell lymphoma. | Nat Commun | 2026 | https://conductscience.org/library/papers/42816487 | PubMed |
| 42765032 | Photothermal-driven sequential immunotherapy overcomes resistance to PARP inhibition in Brca1-deficient triple-negative breast cancer. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42765032 | PubMed |
| 42748914 | Single-cell and spatial multi-omics reveal a recurrent multicellular niche at the tumor-stroma interface in multidrug resistance. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42748914 | PubMed |
| 42724741 | Remodeling the tumor immune microenvironment: mechanisms of crosstalk between regulated cell death macrophages. | Front Immunol | 2026 | https://conductscience.org/library/papers/42724741 | PubMed |
| 42718529 | The paracrine effects of tumor cells on endothelial cells and macrophages in brain metastases with different primary sites. | Front Immunol | 2026 | https://conductscience.org/library/papers/42718529 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36924769
GET https://conductscience.org/api/papers/v1/36924769/cited_by?page=2